India's Rubicon Research hits record high after quarterly profit more than doubles
BUZZ-India's Rubicon Research hits record high after quarterly profit more than doubles ** Drug formulations firm Rubicon Research's RUBI.NS shares rise 12.2% to 1,128 rupees, touching an all-time high
** Q4 profit jumps 111.8%; revenue from operations up 43.5%
** Recommends dividend of 1.5 rupees/shr
** Says revenue traction is likely to continue to be stronger than anticipated
** Adds, strong revenue traction coupled with own manufacturing capacity constraint had led to a larger reliance on outsourced manufacturing since the last quarter
** Says larger than anticipated reliance on outsourced manufacturing could further contract gross margin % in the near term
** 24 products were under review by U.S. FDA as of 31 March, RUBI.NS says
** YTD, stock up 66% vs 1% decline in Nifty Smallcap 500 Index .NIFTYSMALLCAP500
(Reporting by Abhinav Parmar in Bengaluru)
Recent news on Rubicon Research
See all newsIndia's Rubicon Research hits record high after quarterly profit more than doubles
Brief: Rubicon Research Says Total Tax Demand Raised Amounts To 172.5 Million Rupees
Brief: Rubicon Research To Buy 85% Stake In Arinna Lifesciences
Brief: Rubicon Research Buys 85% Equity Ownership In Arinna Lifesciences
India's Rubicon Research hits record high as quarterly profit nearly doubles